Meetings Set To Address EU Delegated & Implementing Acts
Executive Summary
With the EU’s new medtech regulations due to enter into force in as little as four months’ time, meetings have been set on the European Commission calendar to start addressing the crucial "delegated and implementing acts" for making the changes a reality. Also, an overview of the 2017 calendar for key EU medtech policymaking bodies.
You may also be interested in...
Germany – Still Europe's Stand-Out Medtech Innovation Market
Germany's introduction of benefit assessments for class IIb and class III medical devices, and the impending EU Medical Device and IVD Regulations will place an unquantified strain on medtech manufacturers in Europe's largest market. But new innovation schemes are adding more dimensions for businesses locally.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.